Discover
ENVB
Enveric Biosciences, Inc.
1.37
1 x 1.36
1 x 1.42
bid
ask
+
0.05
3.79%
11:53 AM
timesize
| Ytd | -62.26% | |
| 1y | -91.90% |
1.30
day range
1.44
1.26
52 week range
17.64
| Open | 1.30 | Prev Close | 1.32 | Low | 1.30 | High | 1.44 | Mkt Cap | 788.06K |
| Vol | 103.90K | Avg Vol | 1.11M | EPS | -22.68 | P/E | -0.06 | Forward P/E | -0.22 |
| Beta | 1.15 | Short Ratio | 0.31 | Inst. Own | 7.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 04-23 | Earning | 08-15 | 50-d Avg | 1.75 | 200-d Avg | 3.72 | 1yr Est | 8.32 |
| Income Statement | |||
| Operating Expenses | 1.63M | ||
| Research and Development Expense | 345.97K | ||
| Selling, General and Administrative Expense | 1.25M | ||
| Operating Income | -1.63M | ||
| Interest Expense | 303.00 | ||
| Net Income | -1.63M | ||
| Net Income Common Stock | -1.63M | ||
| Net Income Common Stock (USD) | -1.63M | ||
| Consolidated Income | -1.63M | ||
| Earnings per Basic Share | -1.08 | ||
| Earnings per Basic Share (USD) | -1.08 | ||
| Earnings per Diluted Share | -1.08 | ||
| Earning Before Interest & Taxes (EBIT) | -1.63M | ||
| Earning Before Interest & Taxes (USD) | -1.63M | ||
| Weighted Average Shares | 1.51M | ||
| Weighted Average Shares Diluted | 1.51M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.91M | ||
| Cash and Equivalents (USD) | 4.91M | ||
| Current Assets | 5.38M | ||
| Property, Plant & Equipment Net | 119.93K | ||
| Total Assets | 5.52M | ||
| Current Liabilities | 460.68K | ||
| Total Liabilities | 460.68K | ||
| Accumulated Retained Earnings (Deficit) | -116.48M | ||
| Accumulated Other Comprehensive Income | -587.06K | ||
| Shareholders Equity | 5.06M | ||
| Shareholders Equity (USD) | 5.06M | ||
| Assets Non-Current | 146.37K | ||
| Trade and Non-Trade Payables | 280.32K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 37.24K | ||
| Net Cash Flow from Financing | 2.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 231.28K | ||
| Issuance (Purchase) of Equity Shares | 2.50M | ||
| Net Cash Flow from Operations | -2.26M | ||
| Effect of Exchange Rate Changes on Cash | -15.09K | ||
| Share Based Compensation | 88.67K | ||